Literature DB >> 23021380

Strong effects of environmental factors on prevalence and course of major depressive disorder are not moderated by 5-HTTLPR polymorphisms in a large Dutch sample.

Wouter J Peyrot1, Christel M Middeldorp, Rick Jansen, Johannes H Smit, Eco J C de Geus, Jouke-Jan Hottenga, Gonneke Willemsen, Jacqueline M Vink, Susanne Virding, Isabel Barragan, Magnus Ingelman-Sundberg, Sarah C Sim, Dorret I Boomsma, Brenda W J H Penninx.   

Abstract

BACKGROUND: There is ongoing interest in the possible interaction of the serotonin-transporter-linked polymorphic region (5-HTTLPR) with environmental factors in determining Major Depressive Disorder (MDD). The current study contributes to this research area by comprehensively examining the interaction-effects and direct-effects of 5-HTTLPR and five environmental factors on MDD prevalence and course in a well-characterized longitudinal sample.
METHODS: The sample consisted of 1625 patients with a CIDI-confirmed diagnosis of MDD and 1698 screened controls from the Netherlands. Four MDD outcomes were studied as dependent variables: one main MDD prevalence-outcome (all MDD), two more severe MDD prevalence-outcomes (suicidal and chronic MDD), and one MDD course outcome (chronic versus non-chronic MDD). Because SNP rs25531 modifies the effect of 5-HTTLPR, haplotypes of 5-HTTLPR and rs25531 were measured. For the four MDD outcome measures, we examined the direct effects of 5-HTTLPR/rs25531-haplotypes, five environmental factors (lifetime and recent stressful life-events, sexual abuse, low educational attainment, and childhood trauma) and their interaction in logistic regression models.
RESULTS: The environmental factors had large and consistent effects on all four MDD outcomes, including course of MDD. The 5-HTTLPR/rs25531-haplotype had a suggestive effect on course of MDD, but not on presence of MDD. Gene-by-environment interaction was significant (<0.05) for one of the 20 tests performed, which is not more than expected by chance. LIMITATIONS: Environmental factors were not assessed before the onset of MDD.
CONCLUSIONS: Environmental factors had a strong impact on the presence and course of MDD, but no evidence for gene-by-environment interaction was found.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23021380     DOI: 10.1016/j.jad.2012.08.044

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  11 in total

Review 1.  Gene-environment interactions in genome-wide association studies: current approaches and new directions.

Authors:  Stacey J Winham; Joanna M Biernacka
Journal:  J Child Psychol Psychiatry       Date:  2013-06-28       Impact factor: 8.982

2.  Effect of polygenic risk scores on depression in childhood trauma.

Authors:  Wouter J Peyrot; Yuri Milaneschi; Abdel Abdellaoui; Patrick F Sullivan; Jouke J Hottenga; Dorret I Boomsma; Brenda W J H Penninx
Journal:  Br J Psychiatry       Date:  2014-06-12       Impact factor: 9.319

3.  "Out, out, brief candle! Life's but a walking shadow": 5-HTTLPR Is Associated With Current Suicidal Ideation but Not With Previous Suicide Attempts and Interacts With Recent Relationship Problems.

Authors:  Janos Bokor; Sandor Krause; Dora Torok; Nora Eszlari; Sara Sutori; Zsofia Gal; Peter Petschner; Ian M Anderson; Bill Deakin; Gyorgy Bagdy; Gabriella Juhasz; Xenia Gonda
Journal:  Front Psychiatry       Date:  2020-06-25       Impact factor: 4.157

Review 4.  Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors.

Authors:  Deepika Suri; Cátia M Teixeira; Martha K Caffrey Cagliostro; Darshini Mahadevia; Mark S Ansorge
Journal:  Neuropsychopharmacology       Date:  2014-09-02       Impact factor: 7.853

5.  Effects of Recent Stress and Variation in the Serotonin Transporter Polymorphism (5-HTTLPR) on Depressive Symptoms: A Repeated-Measures Study of Adults Age 50 and Older.

Authors:  Thalida E Arpawong; Jinkook Lee; Drystan F Phillips; Eileen M Crimmins; Morgan E Levine; Carol A Prescott
Journal:  Behav Genet       Date:  2015-09-02       Impact factor: 2.805

6.  A genetic variant in 12q13, a possible risk factor for bipolar disorder, is associated with depressive state, accounting for stressful life events.

Authors:  Ayu Shimasaki; Kenji Kondo; Takeo Saito; Kosei Esaki; Yasuyo Otsuka; Keiko Mano; Masashi Ikeda; Nakao Iwata
Journal:  PLoS One       Date:  2014-12-17       Impact factor: 3.240

7.  The association of childhood maltreatment with depression and anxiety is not moderated by the oxytocin receptor gene.

Authors:  Marieke S Tollenaar; Marc L Molendijk; Brenda W J H Penninx; Yuri Milaneschi; Niki Antypa
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-03-28       Impact factor: 5.270

Review 8.  Antidepressant treatment response is modulated by genetic and environmental factors and their interactions.

Authors:  Dávid Kovacs; Xénia Gonda; Péter Petschner; Andrea Edes; Nóra Eszlari; György Bagdy; Gabriella Juhasz
Journal:  Ann Gen Psychiatry       Date:  2014-06-13       Impact factor: 3.455

9.  Socioeconomic Inequalities in Psychological Distress among Urban Adults: The Moderating Role of Neighborhood Social Cohesion.

Authors:  Özcan Erdem; Frank J Van Lenthe; Rick G Prins; Toon A J J Voorham; Alex Burdorf
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

10.  Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression.

Authors:  R C Culverhouse; N L Saccone; A C Horton; Y Ma; K J Anstey; T Banaschewski; M Burmeister; S Cohen-Woods; B Etain; H L Fisher; N Goldman; S Guillaume; J Horwood; G Juhasz; K J Lester; L Mandelli; C M Middeldorp; E Olié; S Villafuerte; T M Air; R Araya; L Bowes; R Burns; E M Byrne; C Coffey; W L Coventry; K A B Gawronski; D Glei; A Hatzimanolis; J-J Hottenga; I Jaussent; C Jawahar; C Jennen-Steinmetz; J R Kramer; M Lajnef; K Little; H M Zu Schwabedissen; M Nauck; E Nederhof; P Petschner; W J Peyrot; C Schwahn; G Sinnamon; D Stacey; Y Tian; C Toben; S Van der Auwera; N Wainwright; J-C Wang; G Willemsen; I M Anderson; V Arolt; C Åslund; G Bagdy; B T Baune; F Bellivier; D I Boomsma; P Courtet; U Dannlowski; E J C de Geus; J F W Deakin; S Easteal; T Eley; D M Fergusson; A M Goate; X Gonda; H J Grabe; C Holzman; E O Johnson; M Kennedy; M Laucht; N G Martin; M R Munafò; K W Nilsson; A J Oldehinkel; C A Olsson; J Ormel; C Otte; G C Patton; B W J H Penninx; K Ritchie; M Sarchiapone; J M Scheid; A Serretti; J H Smit; N C Stefanis; P G Surtees; H Völzke; M Weinstein; M Whooley; J I Nurnberger; N Breslau; L J Bierut
Journal:  Mol Psychiatry       Date:  2017-04-04       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.